Index Abortion, 785-789 Adenocarcinoma-Cant. gross examination of tissue from, 885-888 of vagina habitual, 788 clear cell, and prenatal exposure to DES, 99-105 induced, 788-789 relation to adenosis, 70, 71 missed, 788 of vulva, 50 spontaneous, 785-787 Adenofibroma in endometritis, 281 of cervix uteri, papillary, 151-152 threatened, 788 of ovary . Abruptio placentae, 779 benign, 523-525 Abscess malignant, 525 Bartholin, 26 of uterus, 371-373 ovarian, 442-443 Adenohypophysial-ovarian axis, 229-230 tubovarian, 442-443 Adenomatoid tumors mesothelioma of uterus, 385-386 Acatalasemia, prenatal diagnosis of, 807 of ovary, 553-554, 572 Acid phosphatase deficiency, lysosomal, prenatal diagnosis tubal, 407 of, 810 Adenomyoma of cervix uteri, 152 Acrochordon of vulva, 30 Adenomyosis, 297-299 Actinomycosis, genital, 141 and carcinoma, 299 in IUD users, 293-294 Adenosarcoma oophoritis in, 445 of ovary, 538-539 salpingitis in, 402 of uterus, 373-376 Adenoacanthoma of ovary, 536 Adenosis, vaginal Adenocarcinoma atypical, from prenatal exposure to DES, 109-111 cervical, 200-207 from prenatal exposure to DES, 69-71, 105-108 cytologic diagnosis of, 854-855 Adenovirus infection, cytologic findings in, 849 in cervical polyp, 143-144 Adolescence, ovarian neoplasms in, 665-700 clear cell, cytologic diagnosis of, 861 Adrenogenital syndrome, 10 in endometriosis of rectovaginal septum, 474-475 and female pseudohermaphroditism, 504-505 of endometrium, 330-333 and male pseudohermaphroditism, 504 of ovary, 532-538, 554 prenatal diagnosis of, 807 cytologic diagnosis of, 860 Age tubal and endometrial secretions, 247 cytologic diagnosis of, 860 ovarian changes with, 437-440 invasive, 409-410 Albinism, vulva in, 34 917 918 Index Alkylating agents, cytologic changes from, 858-859 Animal tumor models-Cant. Amebiasis, ulceronecrotic, cervical, 140 induction of, 902-905 Amenorrhea, 232 from intrauterine devices, 904 secondary, from oral contraceptives, 291 from radiation, 905 in Stein-Leventhal syndrome, 460 spontaneous, 901-902 vaginal smears in, 865 from viruses, 905 Amniocentesis, 806 vaginal, 905-908 early, 807 vulval, 905-908 time-dependent factors in, 805 Anomalies Amnion, 769 of uterus, 10-11 meconium-stained,769-770 of vagina, 71-72 nodosum, 770 of vulva, 15-16 rupture of, 769 arAntitrypsin, in endodermal sinus tumor of ovary, 621 Amnionitis, 770 Apocrine glands of vulva, 14 Amniotic fluid, 769 Arborization of cervical mucus, 124 biochemical assays of, 804-816 Arcuate arteries, 237 creatine phosphokinase levels in fetal death, 806-807 Argininosuccinic aciduria, prenatal diagnosis of, 807 in erythroblastosis fetalis, 812 Argyrophil cell carcinoma of endometrium, 335-336 for fetal lung maturity, 813-816 Arias-Stella phenomenon, 112-114 and fetal maturity estimation, 812-813 differential diagnosis of, 206, 283 a-fetoprotein levels in neural tube defects, 811 in ectopic pregnancy, 767 indications for, 804-805 Arrhenoblastoma of ovary, in childhood, 693 lecithin: sphingomyelin ratio in, 813-815 Arteritis of cervix, 142 obtaining specimens for, 806 Ascariasis, gynecologic smears in, 849 predelivery, 812-813 Asherman syndrome, 294-295 and prenatal diagnosis of fetal disorders, 807-811 infertility in, 832-833 time-dependent factors in, 805-806 Aspiration embolism of, 773 endometrial, 866 Anaplasia, pink cell, endometrial, 264 for ovarian cytology, 716-739 Androblastomas of ovary, 590-597 accuracy of, 747-750 Androgens in benign cystomas, 743-744 actions during menstrual cycle, 227 in carcinomas, 744-745 ovarian synthesis of, 226 and cells from normal organs, 742-743 and tumor induction in animals, 896-897, 906 corpus luteum in, 724-725, 726-729 Anemia, hemolytic, and teratoma of ovary, 635 diagnosis with, 747-749 Angiokeratoma of vulva, 28 in endometriosis, 725, 730-732, 743 Angiosarcoma follicle in, 716-724 of ovary, 565 in germ cell tumors, 745-746 of vulva, 50 in metastatic tumors, 746-747 Animal tumor models, 891-909 in sex cord-stromal tumors, 745 and animals as hosts for human tumors, 908 in soft tissue tumors, 746 cervical, 905-908 stroma in, 725, 738-739 choriocarcinoma, 900-901 surface epithelium in, 725, 733-737 ovarian, 891-901 technique of, 741-742 from bright illumination, 896 in teratomas, 746 from chemical carcinogens, 898-899 in tumors, 741-750 from genetic selection, 894 typing of tumors with, 749-750 from hormone exposure, 896-897 of posterior fornix, 866 induction of, 894-899 Auspitz sign, in psoriasis, 25 from intrasplenic grafting to castrates, 895-896 Autosomal chromosomal aberrations, 498-499 from mutant genes, 894-895 from radiation, 897-898 spontaneous, 891-893 Barr bodies, 484 from transplantation, 895 Bartholin glands, 13, 14 from vasoligation, 895 cysts of, 26 relevance to human disease, 908-909 malignancies of, 50 teratomas and yolk-sac tumors, 899-900 Basal cell(s), in gynecologic smears, 839-840 uterine, 901-905 Basal cell nevus syndrome, ovarian fibroma in, 589 from chemical carcinogens, 903-904 Behc;et's syndrome, genital ulcers in, 24 from hormone imbalance, 902-903 Benzo[a]pyrene, and tumor induction in animals, 904, 906 Index 919 Berger's tumor of ovary, in childhood, 691-693 Carcinoma-Cant. Bilharziasis. See Schistosomiasis embryonal, 612, 618, 622-624, 670-672 Biopsy endometrioid, 532-538 and aspiration cytology of ovaries. See Aspiration, for of low malignant potential, 515-517, 528-529 ovarian cytology vitalline, 672 cervical, 182-183 yolk-sac, 672-673 of vulva, 52 and Paget's disease of vulva, 44-45 Blastomycosis, endometritis in, 283 transformation from genital condylomata, 17 Bleeding tubal, in situ, 408-409 dysfunctional uterine, 285-288 urethral, 51 in normal menstrual cycle, 286 of vagina vaginal, in cervical cancer, 192-193, 200 basal cell-like, 84 Bone, in endometrial stromal cells, 268, 305 in infancy, 84-85 Botryoid sarcoma. See Sarcoma, botryoid in situ, and dysplasia, 81-84 Breast squamous cell, 78-80 accessory tissue in vulva, 30 of vulva cancer metastasis to ovaries, 710 in situ, 40-42 Brenner tumors squamous cell, invasive, 45-48 of ovary, 547-553 Carcinosarcoma benign, 547-551 of ovary, 539-540 malignant, 552-553 tubal,410 proliferating, 551-552 Cartilage, in endometrial stromal cells, 268, 305 of uterus, 303 Caruncles, urethral, 51 Broad ligament Cervical mucus, 124 adrenal rests in, 411 abnormalities in secretion of, and infertility, 834 embryology of, 6-7 ferning of, 124 wolffian adenoma of, 411 in pregnancy, 133 Bromocriptine, and tumor induction in animals, 903 Cervicitis Buccal smear, for sex chromatin determination, 484 acute, nonspecific, 136-137 Burkitt's lymphoma of ovary, 573, 695 chronic, nonspecific, 137 Busulfan, cytologic changes from, 858 tuberculous, 140 Cervicovaginitis, emphysematous, 141 Cervix uteri Call-Exner bodies, 433, 583, 716 abnormalities of, and infertility, 834-835 Call-Exner-like bodies, in gonadoblastoma, 649-650 actinomycosis of, 141 Calymmatobacterium granulomatis infection, 21-22 adenocarcinoma of, 200-207 Candida infection clear cell, and prenatal exposure to DES, 99-105 cervical, 136 cytologic diagnosis of, 854-855 endometritis in, 283 diagnosis of, 200 gynecologic smears in, 846 differential diagnosis of, 206 of vagina, 66-67 etiology and pathogenesis of, 200-201 of vulva, 23 gross morphology of, 201 Carbo wax 1000, and tumor induction in animals, 907 incidence of, 200 Carcinoembryonic antigen microscopic morphology and ultrastructure of, 201- in cervical adenocarcinoma, 206 206 in endodernal sinus tumor of ovary, 621 modes of spread, 206 in endometrial carcinoma, 341 prognosis of, 206 Carcinogens, chemical, and tumor induction in animals, symptoms and signs of, 200 898-899, 903-904, 906-907 treatment of, 207 Carcinoid tumors adenofibroma of, papillary, 151-152 of cervix, 210 adenoid cystic carcinoma of, 210 of ovary, 639-643 adenomyoma of, 152 Carcinoma adenosquamous carcinoma of, 208 cervical. See Cervix uteri argyrophil cell carcinoma of, 213 endometrial, 311-347 atypia of repair, 137-138 cytologic diagnosis of, 859-860 biopsy specimens, processing of, 869 metastatic to ovary, 705-715 carcinoid tumors of, 210 of ovary carcinoma in situ, 156-175 aspiration cytology of, 744-745 cytologic diagnosis of, 851-852 clear cell, 542-547 cervicovaginitis emphysematosa, 141 920 Index Cervix uteri-Cont. Cervix uteri-Cont. colposcopy of, 178-179 metastatic disease of, 218-219 columnar epithelium of, 123-126 micro glandular hyperplasia of, 144-146 condylomatous lesions of, 148-151 in pregnancy, 133 cytologic findings in, 848-849 from prenatal exposure to DES, 111-112 giant condylomata acuminata of Bushke and Lowen­ microinvasive carcinoma of, 184-190 stein, 150, 200 characteristics of, 184-186 conization biopsy of, 183, 869-871 diagnosis of, 186 curettage, endocervical, 183 histology of, 187-189 processing of curettings from, 869 incidence of, 186 cytologic examination of, 182 symptoms and signs of, 186 dysplasia of, 156-175 treatment of, 189-190 ectropion of, 126 morphology and physiology of, 120-126 from prenatal exposure to DES, 108 mucoepidermoid carcinoma of, 210 endometriosis of, 152-154 multiple carcinoma of, 213-214 entropion of, 127 neural tissue in, 146-147 fibroadenoma of, 152 occult invasive carcinoma of, 190-191 glassy cell carcinoma of, 208-210 papilloma of children, mesonephric, 152 gross anatomy of, 119-120 parasitic infections of, 140-141 changes from prenatal exposure to DES, 106 polyps of, 142-144 hemangioma of, 147-148 adenocarcinomatous changes in, 143-144 herpeslike lesions of, 141-142 decidual, 143 in herpesvirus infection, 139 fibrous, 142 heterotopic